N/A N=48 Randomized Treatment

ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

Implant

Bottom Line

View on ClinicalTrials.gov: NCT01066780 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2012

Primary outcome: Primary: Speech Perception of Standardized Sentences Presented From Recorded Format in Speech-spectrum Noise — 8.7; 10.6 percentage of words scored correctly

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: ClearVoice (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Advanced Bionics
Primary completion: Sep 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Speech Perception of Standardized Sentences Presented From Recorded Format in Speech-spectrum Noise	8.7; 10.6	—
SECONDARY The AzBio Sentences Will be Administered in Recorded Format in Multi-talker Babble.	—	—

Summary

The purpose of this study is to collect information about how the new sound-processing affects the ability to hear in everyday listening situations.

Eligibility Criteria

Inclusion Criteria

Post-lingually deafened,
experienced (6 months device use),
adult users of the Harmony HiResolution Bionic Ear System and HiRes Fidelity 120 sound processing.
English language proficiency

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01066780). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.